1052 Tissue-specific interferon-gamma drives regulatory T-cells to restrain DC1-mediated priming of cytotoxic T-cells against lung cancer
Maria Zagorulya(The Francis Crick Institute), Stefani Spranger(University of Chicago), Noor Momin(Massachusetts Institute of Technology), Brendan Horton(University of Chicago), Chloe McCreery(Massachusetts Institute of Technology), Elen Torres-Mejia(Allen Institute), Duncan M. Morgan(IIT@MIT), Leon Yim(Allen Institute), Izabella Zamora(IIT@MIT), J Love(Massachusetts Institute of Technology), A. B. Edwards(University of California, San Francisco), K Wittrup(Massachusetts Institute of Technology)
Cited by 1
Related Papers
Impact of oncogenic pathways on evasion of antitumour immune responses
|Nature reviews. Cancer|2018|652
Increased demand for NAD+ relative to ATP drives aerobic glycolysis
|Molecular Cell|2020|561
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
|Journal for ImmunoTherapy of Cancer|2014|543
Recruited macrophages elicit atrial fibrillation
|Science|2023|212